The Aliskiren for GEriatric LowEring of SyStolic hypertension ( AGELESS ) study in elderly patients with systolic hypertension showed that aliskiren-based therapy provided greater reductions in peripheral BP than ramipril-based therapy over 12 and 36 weeks of treatment .